<!DOCTYPE html>
<html lang="en">
<head>
	<title>AFB/TB Susceptibility Ethionamide (Rapid- MGIT) - Price, Normal Range | Sprint Diagnostics Hyderabad</title>
	<meta charset="utf-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">
	<meta name="description" content="The AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test is a laboratory method designed to evaluate the sensitivity of Mycobacterium tuberculosis (M.TB), the bacteria that cause tuberculosis (TB), to Ethionamide, an antibiotic used to treat this disease.">
	<meta property="og:title" content="AFB/TB Susceptibility Ethionamide (Rapid- MGIT) - Price, Normal Range | Sprint Diagnostics Hyderabad"/>
	<meta property="og:description" content="The AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test is a laboratory method designed to evaluate the sensitivity of Mycobacterium tuberculosis (M.TB), the bacteria that cause tuberculosis (TB), to Ethionamide, an antibiotic used to treat this disease."/>
	<meta property="og:url" content="https://www.sprintdiagnostics.in<?php echo $_SERVER['REQUEST_URI'];?>" />
 	<meta property="og:image" content="https://www.sprintdiagnostics.in/images/logo.webp" />
	<meta property="og:image:width" content="180"/>
	<meta property="og:image:height" content="60"/>
	<!-- Stylesheets -->
	
	<!-- schema Starts Here -->

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "MedicalTest",
  "@id": "MedicalTest",
  "additionalType": "MedicalTest",
  "alternateName": "AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)",
  "description": "The AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test is a laboratory method designed to evaluate the sensitivity of Mycobacterium tuberculosis (M.TB), the bacteria that cause tuberculosis (TB), to Ethionamide, an antibiotic used to treat this disease.",
  "disambiguatingDescription": "The test is used to determine the presence of Mycobacterium tuberculosis complex (M.TB) in a patient's sample and evaluate its susceptibility to Ethionamide.",
  "name": "AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)",
  "mainEntityOfPage": "https://www.sprintdiagnostics.in/hyderabad/test/afb-tb-susceptibility-ethionamide-rapid-mgit",
  "url": "https://www.sprintdiagnostics.in/hyderabad/test/afb-tb-susceptibility-ethionamide-rapid-mgit"
}
</script>

<script type="application/ld+json">
{
  "@context": "https://schema.org/", 
  "@type": "BreadcrumbList", 
  "itemListElement": [{
    "@type": "ListItem", 
    "position": 1, 
    "name": "Home",
    "item": "https://www.sprintdiagnostics.in"  
  },{
    "@type": "ListItem", 
    "position": 2, 
    "name": "Test",
    "item": "https://www.sprintdiagnostics.in/test"  
  },{
    "@type": "ListItem", 
    "position": 3, 
    "name": "AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)",
    "item": "https://www.sprintdiagnostics.in/hyderabad/test/afb-tb-susceptibility-ethionamide-rapid-mgit"  
  }]
}
</script>

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [{
    "@type": "Question",
    "name": "What does AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test measure?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "This test determines the susceptibility of Mycobacterium tuberculosis to Ethionamide. This information helps assess if Ethionamide would be effective in treating the TB infection."
    }
  },{
    "@type": "Question",
    "name": "How often should I take AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "Your healthcare provider usually determines the frequency of this test. It is generally done when a diagnosis of TB is confirmed and there is suspicion of drug resistance."
    }
  },{
    "@type": "Question",
    "name": "What is the normal value for this AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "A normal result shows that M.TB is sensitive to Ethionamide, indicating that the antibiotic should effectively treat the infection."
    }
  }]
}
</script>

<!-- schema Ends Here -->

	

	<?php include '../../side-nav.php';?>
	<div class="page-content">
		<!--section-->
		<div class="section mt-0">
			<div class="breadcrumbs-wrap">
				<div class="container">
					<div class="breadcrumbs">
						<a href="https://sprintdiagnostics.in/">Home</a>
						<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
						<span>AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)</span>
					</div>
				</div>
			</div>
		</div>
		<!--//section-->
		<!--section-->
		<div class="section page-content-first">
			<div class="container mt-6">
				<div class="row">
					<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
 					<h1 class="test-h1">AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)</h1>
					<div class="post-text">
								<p><strong>The AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)</strong> test is a laboratory method designed to evaluate the sensitivity of Mycobacterium tuberculosis (M.TB), the bacteria that cause tuberculosis (TB), to Ethionamide, an antibiotic used to treat this disease. The results of this test enable healthcare providers to design an appropriate and effective treatment regimen for patients diagnosed with TB.</p>
								<p>The test is used to determine the presence of Mycobacterium tuberculosis complex (M.TB) in a patient's sample and evaluate its susceptibility to Ethionamide. The MGIT (Mycobacteria Growth Indicator Tube) method is employed in this test, allowing for quicker results compared to conventional culture methods.</p>
								<p>Tuberculosis is a significant global health concern. With the rise of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), managing TB has become more challenging. Therefore, knowing the antibiotic susceptibility pattern of the TB-causing bacteria is essential for successful treatment.</p>
								
								<div class="table-wrap">
									<table class="table table-striped">
							  <thead>
							    <tr>
							      <th scope="col">Test Name</th>
							      <td scope="col">AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)</td>
							      
							    </tr>
							  </thead>
							  <tbody>
							    <tr>
							      <th scope="row">Sample Type</th>
							      <td>Sputum, BAL, Tissue, Body Fluids</td>
							      
							    </tr>
							    <tr>
							      <th scope="row">Preparations Required</th>
							      <td>No specific preparation is needed for this test.</td>
							      
							    </tr>
							    <tr>
							      <th scope="row">Report Time</th>
							      <td>4 weeks</td>
							      
							    </tr>
								<tr>
							      <th scope="row">Price</th>
							      <td>â‚¹ 2600</td>
							      
							    </tr>
							  </tbody>
							</table>
						</div>
					<div class="post-text">
						<h2 class="test-h2 mt-3">Do I need to fast for this test?</h2>
						<p>No, there is no fasting requirement for this test.</p>

						<h2 class="test-h2 mt-3">What preparation is required for AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test?</h2>
						<p>No special preparation is needed for this test. However, your healthcare provider will guide you regarding the sample collection process.</p>

						<!--section achieved-->
						<?php include "../../include/iconsbox.php" ?>
						<!--//section achieved-->

						<h2 class="test-h2 mt-3">When should AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test be done?</h2>
						<p>This test is generally ordered after a patient is diagnosed with TB, particularly if drug-resistant TB is suspected.</p>

						<h2 class="test-h2 mt-3">What does this test measure?</h2>
						<p>This test determines the susceptibility of Mycobacterium tuberculosis to Ethionamide. This information helps assess if Ethionamide would be effective in treating the TB infection.</p>

						<h2 class="test-h2 mt-3">How often should I take this test?</h2>
						<p>Your healthcare provider usually determines the frequency of <strong>AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test</strong>. It is generally done when a diagnosis of TB is confirmed and there is suspicion of drug resistance.</p>

						<h2 class="test-h2 mt-3">What is the normal value for this test?</h2>
						<p>A normal result shows that M.TB is sensitive to Ethionamide, indicating that the antibiotic should effectively treat the infection.</p>

						<h2 class="test-h2 mt-3">What precautions should I take?</h2>
						<p>This test should be done under the supervision of a healthcare provider. The sample collection process needs to be sterile to avoid contamination, which could lead to inaccurate results.</p>

						<h2 class="test-h2 mt-3">What factors can affect the test's results?</h2>
						<p>Several factors, such as the quality of the sample, the presence of inhibitors in the sample, and the specific method used in the test, can affect the results.</p>

						<h2 class="test-h2 mt-3">Whom should I consult if the AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test result is abnormal?</h2>
						<p>In the event of an abnormal result indicating drug resistance, you should consult with a healthcare provider specializing in infectious diseases or pulmonology.</p>

						<h2 class="test-h2 mt-3">Can medications or health conditions affect the results?</h2>
						<p>Yes, certain medications and existing health conditions can impact the test results. Always inform your healthcare provider about all medications, supplements, and existing health conditions before the test.</p>

						<h2 class="test-h2 mt-3">Can pregnant women undergo this test?</h2>
						<p>Yes, pregnant women can safely undertake this test if it is deemed necessary by a healthcare provider.</p>

						<h2 class="test-h2 mt-3">Are there any risks associated with the AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test?</h2>
						<p>The risks associated with this test are minimal and mostly related to the sample collection process. These might include mild discomfort or, rarely, infection at the collection site.</p>

						<h2 class="test-h2 mt-3">Can children undergo this test?</h2>
						<p>Yes, children can undergo this AFB/TB Susceptibility: Ethionamide (Rapid- MGIT) test if it is recommended by a healthcare provider.</p>

						<p>The susceptibility of Mycobacterium tuberculosis to Ethionamide can considerably improve the treatment outcomes for patients with tuberculosis, particularly those with drug-resistant forms of the disease. The <strong>AFB/TB Susceptibility: Ethionamide (Rapid- MGIT)</strong> test provides crucial information that helps in crafting the most effective treatment plan. Always heed your healthcare provider's advice regarding the necessity of this test and interpretation of its results.</p>

							</div>		
						</div>			
				</div>

		    <!--form section-->
				<?php include "../../include/bookslot.php" ?>
       <!--form section-->

			</div>
		</div>
		<!--//section-->
	</div>
	<?php include '../../footer.php';?>
</body>
</html>